Propranolol Hydrochloride | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Propranolol Hydrochloride
US Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Propranolol Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

44 API Suppliers, 24 USDMF, 2 CEP/COS, 2 JDMF, 4 EU WC, 10 NDC API, 20 Listed Suppliers, $ API Reference Price

44 API Suppliers
24 USDMF
2 CEP/COS
2 JDMF
4 EU WC
10 NDC API
20 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

6 Drugs in Development

6 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

347 FDF Dossiers, 209 FDA Orange Book, 44 Europe, 14 Canada, 16 Australia, 16 South Africa, 48 Listed Dossiers

347 FDF Dossiers
209 FDA Orange Book
44 Europe
14 Canada
16 Australia
16 South Africa
48 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE, EXTENDED RELEASE;ORAL - 120MG, CAPSULE, EXTENDED RELEASE;ORAL - 160MG, CAPSULE, EXTENDED RELEASE;ORAL - 60MG, CAPSULE, EXTENDED RELEASE;ORAL - 80MG, CAPSULE, EXTENDED RELEASE;ORAL - 120MG, CAPSULE, EXTENDED RELEASE;ORAL - 80MG

CAPSULE, EXTENDED RELEASE;ORAL - 120MG
CAPSULE, EXTENDED RELEASE;ORAL - 160MG
CAPSULE, EXTENDED RELEASE;ORAL - 60MG
CAPSULE, EXTENDED RELEASE;ORAL - 80MG
CAPSULE, EXTENDED RELEASE;ORAL - 120MG
CAPSULE, EXTENDED RELEASE;ORAL - 80MG

RELATED EXCIPIENT COMPANIES

5 Evonik, 2 Rochem International Inc, 6 SPI Pharma, 2 Seqens, 9 DKSH, 6 Faran Shimi Pharmaceutical, 4 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 5 Actylis, 1 Aeon Procare, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 25 BASF, 1 Clariant, 13 Corel Pharma Chem, 7 DFE Pharma, 2 Finar, 7 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 35 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 2 Nomisma Healthcare, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 6 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 27 Roquette, 8 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 3 The Dow Chemical Company, 1 Ulanqab Kema New Material, 2 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

78 Fillers, Diluents & Binders, 57 Coating Systems & Additives, 32 Controlled & Modified Release, 28 Disintegrants & Superdisintegrants, 27 Granulation, 27 Thickeners and Stabilizers, 25 Taste Masking, 25 Direct Compression, 25 Film Formers & Plasticizers, 19 Lubricants & Glidants, 14 Solubilizers, 13 Topical, 13 Co-Processed Excipients, 10 Parenteral, 9 Empty Capsules, 8 Chewable & Orodispersible Aids, 5 API Stability Enhancers, 5 Coloring Agents, 5 Emulsifying Agents, 4 Vegetarian Capsules, 4 Rheology Modifiers, 2 Surfactant & Foaming Agents, 1 Soft Gelatin

78 Fillers, Diluents & Binders
57 Coating Systems & Additives
32 Controlled & Modified Release
28 Disintegrants & Superdisintegrants
27 Granulation
27 Thickeners and Stabilizers
25 Taste Masking
25 Direct Compression
25 Film Formers & Plasticizers
19 Lubricants & Glidants
14 Solubilizers
13 Topical
13 Co-Processed Excipients
10 Parenteral
9 Empty Capsules
8 Chewable & Orodispersible Aids
5 API Stability Enhancers
5 Coloring Agents
5 Emulsifying Agents
4 Vegetarian Capsules
4 Rheology Modifiers
2 Surfactant & Foaming Agents
1 Soft Gelatin

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 21 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
21 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 62 Finished Drug Prices

2 US Medicaid Prescriptions
62 Finished Drug Prices

MARKET PLACE

21 APIs, 8 FDF Dossiers

21 APIs
8 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 US Patents, 1 Health Canada Patents

2 US Patents
1 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 1 USP, 8 Others

2 EDQM
1 USP
8 Others

ANALYTICAL

3 Analytical Methods

3 Analytical Methods

$ API Ref.Price (USD/KG) : 40 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

2 All

01 2PIERRE FABRE

filter Patent Number Reset all filters

2 All

01 18338489

02 18987262

filter API Patent Reset all filters

2 All

01 2Blank

filter FDF Patent Reset all filters

2 All

01 2Blank

filter Expiration Date Reset all filters

2 All

01 22028-10-16

Product Main Page

01

PIERRE FABRE

PROPRANOLOL HYDROCHLORIDE

PharmScience R&D

Not Confirmed

PIERRE FABRE

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-10-16

PROPRANOLOL HYDROCHLORIDE

US Patent Number : 8338489

Drug Substance Claim :

Drug Product Claim :

Application Number : 205410

Patent Use Code : U-1496

Delist Requested :

Patent Use Description : METHOD TO TREAT HEMANG...

Patent Expiration Date : 2028-10-16

Portfolio PDF

Product Web Link

Digital Content

02

PIERRE FABRE

PROPRANOLOL HYDROCHLORIDE

PharmScience R&D

Not Confirmed

PIERRE FABRE

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-10-16

PROPRANOLOL HYDROCHLORIDE

US Patent Number : 8987262

Drug Substance Claim :

Drug Product Claim :

Application Number : 205410

Patent Use Code : U-1988

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-10-16

Portfolio PDF

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!